JosephRalphTucciMD
Endocrinology • Providence, RIDiabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine, Thyroid
Professor, Medicine, Boston University School of Medicine
Dr. Tucci is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
50 Maude St
Providence, RI 02908Phone+1 401-456-5716Fax+1 401-456-6546
Education & Training
Brigham and Women's HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1965 - 1967
MedStar Health/Georgetown University HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1964 - 1965- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1962 - 1964
St Elizabeth's Medical CenterResidency, Internal Medicine, 1960 - 1962- St Elizabeth's Medical Center/Lemuel Shattuck HospitalInternship, Transitional Year, 1959 - 1960
Boston University School of MedicineClass of 1959
Certifications & Licensure
RI State Medical License 1969 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
- Fellow (FACE) American Association of Clinical Endocrinology
Publications & Presentations
PubMed
- 444 citationsMutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalitiesLynn M. Boyden, Murim Choi, Keith A. Choate, Carol Nelson-Williams, Anita Farhi
Nature. 2012-02-02 - 827 citationsTen years' experience with alendronate for osteoporosis in postmenopausal women.Henry G. Bone, David J. Hosking, Jean-Pierre Devogelaer, Joseph R. Tucci, Ronald Emkey
The New England Journal of Medicine. 2004-03-18 - 164 citationsEffect of three years of oral alendronate treatment in postmenopausal women with osteoporosisJoseph R. Tucci, Richard P. Tonino, Ronald Emkey, Christine A. Peverly, Uma Kher
The American Journal of Medicine. 1996-11-01
Press Mentions
Effect of Alendronate and MK-677 (A Growth Hormone Secretagogue), Individually and in Combination, on Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporotic WomenJuly 22nd, 2020
Huffing Dust Spray: Bone Disease Adds up to Its Adverse EffectsOctober 6th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
